A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

Completed · Phase 3

Conditions studied: Dry Eye Syndromes

In brief

This study will evaluate the safety and efficacy of a new eye drop formulation in patients with dry eye disease.

Key facts

Study ID: NCT02553772
Run by: Allergan
People needed: 242
Starts: 2016-01-06
Expected to finish: 2016-09-09
Last updated by the study team: 2017-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Used artificial tears for dry eye
Visual acuity of at least 20/32 (while wearing glasses, if necessary).

You may not qualify if…

Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study
Herpes keratitis in the last 6 months
Cataract surgery, laser-assisted in situ keratomileusis [LASIK], or photorefractive keratectomy, within the last 6 months

Where it is running

The Private Practice of Milton Hom, OD — Azusa, California, United States
Havana Research Institute LLC — Burbank, California, United States
Lugene Eye Institute — Glendale, California, United States
Eric M. White, OD, INC — San Diego, California, United States
Moyes Eye Center, PC — Kansas City, Missouri, United States
Ophthalmology Associates — St Louis, Missouri, United States
Rochester Ophthalmological Group, PC — Rochester, New York, United States
Charlotte Eye Ear Nose — Charlotte, North Carolina, United States
Scott and Christie and Associate — Cranberry Township, Pennsylvania, United States
Texan Eye — Austin, Texas, United States
Department of Optometry & Vision Sciences, The University of Melbourne — Parkville, Australia
Prof. M.T. Coroneo Pty. Ltd. — Randwick, Australia
The University of New South Wales School of Optometry and Vision Science — Sydney, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.